Media Releases

Pdf downloads.

Lodge Partners retains BUY rating for Benitec	May 8, 2013
UCSD selected as site for HCV ‘in-human’ trials	April 17, 2013
RAC submission moves HCV closer to the clinic	April 16, 2013
Genable gains Orphan Drug status for eye treatment	April 15, 2013
Former CEO of Cephalon Joins Benitec’s Board	April 11, 2013
Lodge Partners says ‘steady progress’ and recommends ‘buy’	April 9, 2013

Benitec Presents at US 6th Annual Pain Therapeutics Summit	December 13, 2012
News Update from Lodge Partners	December 4, 2012
Lodge Partners initiates coverage of Benitec	November 20, 2012
Lodge Partners on Benitec’s Acquisition of Tacere	October 11, 2012
BioShares Update: Benitec's Big Hep C Play	November 16, 2012
Biotech Daily Update	November 16, 2012
BLT Ausbiotech Presn Nov 2012	October 31, 2012
ddRNAi – The New Therapeutic Revolutions? Benitec presents at Australian Microcap Investment Conference	October 17, 2012
Benitec Biopharma to present at San Jose Pain Therapeutics Summit & San Francisco Investor Forum	October 2, 2012
Benitec Strategy Update: Pathways to Revenue	September 25, 2012
Hepatitis B Program meeting review in China 3-6 September 2012	September 6, 2012
Benitec teams with Stanford University on chronic pain research	August 13, 2012
Van Leeuwenhoek Research: Update Report for Benitec Biopharma	August 10, 2012
Bioshares Update	June 2, 2012
Chief Investigators Group Update	June 2012
Technology Update: ddRNAi - The New Therapeutic Revolution?	May 14, 2012

Bioshares Investor Report: Benitec – Building Proof of Concept Data in Four Diseases	November 25, 2011
Van Leeuwenhoeck Institute Report	November 28, 2011
Biotech Daily Release	November 20, 2011